GGrantIndex
← Leaderboards

Fondazone Cent/San Raffaele/Del Monte

Milan

Compare ↔
$3,658,767
Total funding
5
Grants

Funding over time

peak $894.2K · FY200510
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10

Funding mix

By agency

NIH$3,658,767 · 5

By mechanism

R01$3,360,238 · 4
R21$298,529 · 1

Investigators at Fondazone Cent/San Raffaele/Del Monte

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

Not enough data

Largest grants

Laminin receptors and signals in Schwann cells$236,250
R01 · FY2007 · NS
Laminin receptors and signals in Schwann cells$236,250
R01 · FY2009 · NS
Laminin receptors and signals in Schwann cells$236,250
R01 · FY2008 · NS
Pathogenesis of Myelin Protein Zero Neuropathies in Transgenic Mice$235,953
R01 · FY2008 · NS
Pathogenesis of Myelin Protein Zero Neuropathies in Transgenic Mice$235,953
R01 · FY2009 · NS
Pathogenesis of Myelin Protein Zero Neuropathies in Transgenic Mice$235,953
R01 · FY2007 · NS
Laminin receptors and signals in Schwann cells$233,888
R01 · FY2010 · NS
Pathogenesis of Myelin Protein Zero Neuropathies in Transgenic Mice$233,593
R01 · FY2010 · NS
Laminin receptors and signals in Schwann cells$225,425
R01 · FY2006 · NS
Dissecting the Molecular Basis of Ocular Albinism type 1$189,000
R01 · FY2004 · EY
Dissecting the Molecular Basis of Ocular Albinism type 1$189,000
R01 · FY2005 · EY
Dissecting the Molecular Basis of Ocular Albinism type 1$189,000
R01 · FY2003 · EY
Dissecting the Molecular Basis of Ocular Albinism type 1$184,559
R01 · FY2006 · EY
Dissecting the Molecular Basis of Ocular Albinism type 1$183,525
R01 · FY2007 · EY
HIV-Associated Dementia and the Urokinase Plasminogen Activation System$164,959
R21 · FY2006 · MH
HIV-Associated Dementia and the Urokinase Plasminogen Activation System$133,570
R21 · FY2007 · MH
NKT cell-mediated modulation of autoimmune diabetes$108,000
R01 · FY2006 · DK
NKT cell-mediated modulation of autoimmune diabetes$104,868
R01 · FY2007 · DK
NKT cell-mediated modulation of autoimmune diabetes$102,771
R01 · FY2008 · DK